Barbara Schmidt

Title: The Innovative Mind of Barbara Schmidt

Introduction

Barbara Schmidt is a renowned inventor based in Munich, Germany, with a unique contribution to the field of pharmaceuticals. She holds one patent for a method that enhances the isolation of pharmaceutically exploitable etidronate disodium. Her inventive spirit and dedication to scientific advancement have made significant impacts in her industry.

Latest Patents

Barbara Schmidt's patent is titled "Method for isolating pharmaceutically exploitable etidronate disodium." This innovative method involves creating a liquid-liquid dispersion that incorporates an aqueous-organic phase and an etidronate-disodium-salt-containing aqueous phase. It necessitates adjusting the temperature of the dispersion between 0 and 30°C and involves intense agitation to precipitate a coarse-particle fraction. The resulting anhydrous etidronate disodium particulate exhibits a grain size between 0.1 to 1 mm and a bulk density of 0.4 to 0.6 g/cm³, making it highly appropriate for pharmaceutical applications.

Career Highlights

Barbara Schmidt is associated with Schering Aktiengesellschaft, a notable company in the pharmaceutical sector. Her work has focused on developing methods that improve drug formulation and delivery, showcasing her commitment to enhancing medical treatments through innovation.

Collaborations

Throughout her career, Barbara has collaborated with talented coworkers such as Detlef Grawe and Harald Raethe. These partnerships have contributed to fruitful research initiatives and the advancement of pharmaceutical technologies.

Conclusion

Barbara Schmidt’s contributions through her inventive methods highlight her role as a significant figure within the pharmaceutical industry. Her innovative approach to isolating etidronate disodium paves the way for improved pharmaceutical formulations, underscoring the importance of creativity and collaboration in scientific advancement.